Compound C Protects Mice from HFD-Induced Obesity and Nonalcoholic Fatty Liver Disease.

Fang WangYuxing LiuJingjing YuanWenjun YangZhaohui Mo

Published in: International journal of endocrinology (2019)

Our data suggest that compound C is a potent NAFLD suppressor and an attractive therapeutic target for hepatic steatosis and related metabolic disorders.

Keyphrases

high fat diet induced
insulin resistance
high fat diet
metabolic syndrome
high glucose
diabetic rats
weight loss
type diabetes
electronic health record
big data
weight gain
anti inflammatory
oxidative stress
liver fibrosis
machine learning
skeletal muscle
body mass index
wild type
deep learning